Adaptive Biotechnologies Corporation ADPT
28.49 USD +0.62 (+2.22%)
Regular-session close
28.49 0.00 0.00%
After hours · Nov 17, 4:33 PM ET
27.62 Day range 29.18
12.00 52-week range 32.21
- YTD
- +75.43%
- 1 year
- +107.80%
ADPT revenue history
Revenue is income from the company’s ordinary business activities.
276,976,000 USD
FY 2025 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | 276,976,000 | 98,019,000 | 54.77% |
| FY 2024 | 2024-12-31 | 178,957,000 | 8,681,000 | 5.10% |
| FY 2023 | 2023-12-31 | 170,276,000 | -15,032,000 | -8.11% |
| FY 2022 | 2022-12-31 | 185,308,000 | 30,964,000 | 20.06% |
| FY 2021 | 2021-12-31 | 154,344,000 | 55,962,000 | 56.88% |
| FY 2020 | 2020-12-31 | 98,382,000 | 13,311,000 | 15.65% |
| FY 2019 | 2019-12-31 | 85,071,000 | 29,408,000 | 52.83% |
| FY 2018 | 2018-12-31 | 55,663,000 | 17,215,000 | 44.77% |
| FY 2017 | 2017-12-31 | 38,448,000 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-08-07T06:02:14.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.
